Stryker Reports $6.6 Billion Revenue for Q2 Amid Recovery from Cyberattack
Stryker reported second-quarter revenues of $6.6 billion, a year-over-year increase of 9.4%, despite ongoing recovery efforts following an Iran-linked cyberattack in March that disrupted its global operations. The company revised its full-year earnings outlook to the range of $14.95–$15.10 per share from previously projected $14.90–$15.10, reflecting progress but also some caution. The medsurg and neurotechnology segment contributed around $3.6 billion in revenue for Q2—a 9.7% increase YoY—but fell short of analysts' expectations set at $3.72 billion by LSEG data. The orthopaedic segment reported nearly $3 billion, up 9.2%. Stryker's CEO Kevin A Lobo emphasized the company’s resilience and innovation in overcoming operational challenges. Stryker shares were down approximately 5.1% in premarket trading following the results release on July 30.
Tickers: $SYK